March 18, 2026Announcement no. 03 BioPorto Successfully Completes Preliminary Analysis of U.S. Adult NGAL Cutoff Study; Pre-Submission expected by End of...
March 18, 2026Announcement no. 03
BioPorto Successfully Completes Preliminary Analysis of U.S. Adult NGAL Cutoff Study; Pre-Submission expected by End of Q1 2026
COPENHAGEN, DENMARK, March 18, 202… [+5893 chars]





